Mar 17, 2021 / 12:40PM GMT
Suraj Kalia - Oppenheimer & Co. Inc., Research Division - MD & Senior Analyst
Good morning, everyone. This is Suraj Kalia. I'm the senior medical device analyst at Oppenheimer. Pleased to have all of you join us this morning, the second day of the Oppenheimer Annual Healthcare Conference. I am truly pleased to have a unique company start off the day on our side, which is Nyxoah. They are doing some very interesting stuff in obstructive sleep apnea, and I'll let the company talk about it.
Presenting this morning are Olivier Taelman, CEO. Olivier, it's a pleasure to have you. I'll let you take the floor from here.
Olivier Taelman - Nyxoah S.A. - Executive Director & CEO
Okay. Thank you, Suraj, and thank you to the Oppenheimer team for having us and allowing us to share the Nyxoah story. So -- sorry we are -- so maybe I should start with a brief introduction of myself and also Fabian Suarez, our CFO.
So I'm Olivier Taelman, I'm born and raised in Belgium. I spent more than 20 years in the med tech industry, of which almost 10 years
Nyxoah SA at Oppenheimer Healthcare Conference (Virtual) Transcript
Mar 17, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers